Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
Keyword(s):
Abstract Objective To determine at two distinct time points the prevalence of resistance to ofloxacin (OFX), the representative class drug of fluoroquinolones (FQs), in M. tuberculosis isolates susceptible to first-line drugs. Results There were 279 M. tuberculosis isolates from the two cohorts (2004–2005: 238 isolates; 2017: 41 isolates) that underwent OFX drug-susceptibility testing (critical concentration: 2 µg/ml). Of 238 isolates in Cohort 1, no resistance to OFX was detected (95% CI 0–0.016); likewise, in Cohort 2, no resistance to OFX was detected in 41 isolates (95% CI 0–0.086). Our findings suggest that FQ use remains a viable option for the treatment of first-line drug-susceptible TB in Peru.
2011 ◽
Vol 50
(2)
◽
pp. 488-491
◽
2011 ◽
Vol 55
(5)
◽
pp. 2032-2041
◽
Keyword(s):
2009 ◽
Vol 47
(11)
◽
pp. 3630-3634
◽
2017 ◽
Vol 56
◽
pp. 185-189
◽
2016 ◽
Vol 5
(4)
◽
pp. 469-474
◽
2012 ◽
Vol 88
(1)
◽
pp. 122-126
◽